期刊文献+

禽流感病毒免疫血清对实验感染小鼠的紧急预防效果研究 被引量:1

Emergency prophylactic effects of the avian influenza virus immunized serum on the infected mice
原文传递
导出
摘要 目的评价H5NI亚型禽流感病毒免疫血清对实验感染小鼠的紧急预防保护效果。方法给30只小鼠腹腔注射0.2ml/只禽流感病毒免疫血清,注射后l~19d内每天采3只小鼠血清测定血凝抑制(HI)抗体效价,测定免疫血清在小鼠体内的消长规律;给10只小鼠腹腔注射1.5ml/只禽流感病毒免疫血清,检测免疫血清对小鼠的安全性;将70只小鼠按数字表法随机分为7组,分别为正常对照组、病毒对照组以及免疫血清高剂量早期组、高剂量中期组、高剂量晚期组、中剂量组、低剂量组,每组10只,分别在攻毒前8d、4d和1d时腹腔注射血清0.2ml/只、0.1ml/只、0.05ml/只禽流感病毒免疫血清,然后给小鼠滴鼻感染10个半数致死量(LD,。)病毒,攻毒后连续观察14d,计算小鼠存活率和平均存活天数,比较各实验组小鼠肺指数及肺脏病毒感染滴度。结果注射0.2ml免疫血清小鼠m抗体效价在1—15d时为2°,在17d以后开始下降;1.5ml免疫血清注射小鼠全部存活,没有发病;在攻毒前8d、4d和1d时给小鼠腹腔注射0.2ml免疫血清,小鼠存活率分别为80%、100%和100%,平均存活天数分别为13.1d、14.0d和14.0d,在攻毒前1d给小鼠腹腔注射0.1ml和0.05ml免疫血清,小鼠存活率分别为100%和50%,平均存活天数分别为14.0d和11.7d,各实验组小鼠肺指数(0.0096±0.0033—0.0145±0.0060)均小于病毒对照组(0.0199±0.0025),除低剂量组外,均具有统计学意义(P值0.0022—0.0470,〈0.05),各实验组小鼠肺脏病毒滴度(TCID50)较病毒对照组平均低2个滴度。结论禽流感病毒免疫血清对实验感染小鼠具有较好的紧急预防保护效果,可作为人禽流感紧急预防制剂加以研究开发。 Objective To evaluate emergency prophylactic effects of the avian influenza virus immunized serum on experimentally infected mice. Methods Serum HI antibody titers of 30 mice were detected at day 1 to 19 after being inoculated with 0. 2 ml immune serum to estimate half life of immune serum. Ten mice clinical symptom was recorded to estimate the serum security after mice injected 1.5 ml immune serum. Seventy mice were randomly divided into 7 groups according to random number table and inoculated with 0. 2 ml,0. 1 ml and 0. 05 ml immune serum respectively via intraperitoneal injection on day 8,4 and 1 prior to challenged with 10 LDs0 influenza virus intranasal. Mice were observed continually for 14 days to calculate the morbidity, mortality, average survival days and compare the lung index and viral titers in lung. Results Serum HI antibody titers of mice which inoculated with 0. 2 ml immune serum maintained 26 in 15 days after injection,but drawdown after day 17,the mice injected 1.5 ml immune serum were all alive and none onset. The survival rate of mice which injected 0. 2 ml serum on the day 8,4,1 before challenge was 80%, 100% and 100%, and the average survival period was 13.1 days , 14. 0 days and 14. 0 days respectively. The survival rate of mice which injected 0. 1 ml and 0. 05 ml serum on day 1 before challenge was 100% and 50% ,and the average survival days were 14.0 days and 11.7 days respectively. The mice lung index of experimental groups ( 0. 0096 ± 0. 0033 - 0. 0145 ± 0. 0060 ) was smaller than that of viral control group (0. 0199 ± 0. 0025 ) ,with a statistical significance ( P value 0. 0022 - 0. 0470, 〈 0. 05 ). The viral titers in lung were significantly decreased by 2 titer as compared to the viral controls. Conclusion The avian influenza virus immunized serum might contain the emergency prophylactic effects and could be developed as an agent for possible human-avian influenza pandemic.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2008年第11期814-817,共4页 Chinese Journal of Preventive Medicine
基金 军队医药卫生科研基金(042016) 吉林省科技发展计划(20040202-3-1)
关键词 流感病毒A型 免疫血清 免疫法 被动 Influenza A virus,avian Immune sera Immunization,passive
  • 相关文献

参考文献10

  • 1WHO. Cumulative number of confirmed human cases of avian influenza A/( H5N1 ) reported to WHO, World Health Organization [ EB/OL ]. ( 2006-11-29 ). http :// www. who. int / csr/disease/avian influenza/en. htm. 被引量:1
  • 2Luke TC, Kilbane EM, Jackson JL, et al. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future HSN1 treatment? Ann Intern Med,2006,145:599-609. 被引量:1
  • 3殷震,刘景华主编..动物病毒学[M].北京:科学出版社,1985:890.
  • 4Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet, 1998,351:467-471. 被引量:1
  • 5Yen HL, Monto AS, Webster RG, et al. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis ,2005,192:665-672. 被引量:1
  • 6Li KS, Guan Y,Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature ,2004,430:209-213. 被引量:1
  • 7Puthavathana P, Auewarakul P, Charoenying PC, et al. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J Gen Virol, 2005, 86 ( Pt 2 ) : 423-433. 被引量:1
  • 8Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet,2004,363:617-619. 被引量:1
  • 9Yuen KY, Wong SS. Human infection by avian influenza A HSN1. Hong Kong Med J,2005,11:189-199. 被引量:1
  • 10杨松涛,高玉伟,王承宇,邹啸环,苏建青,孙贺廷,常爽,郑晓一,王铁成,王化磊,冯娜,夏咸柱.虎源H5N1亚型禽流感病毒感染小鼠模型的建立[J].中国病毒学,2006,21(4):353-357. 被引量:14

二级参考文献1

共引文献13

同被引文献17

  • 1沈倍奋.治疗性抗体的改造[J].医学分子生物学杂志,2006,3(4):245-249. 被引量:9
  • 2De Bruyn K, Hamelinck W. Influenza vaccines dispensed in corn munity pharmacies during the 2010-2011 flu season[J]. J Pharm Belg, 2011, 12(4) : 117-21. 被引量:1
  • 3Desvaux S, Garcia JM, Nguyen TD, et al. Evaluation of serolog- ical tests for H5N1 avian influenza on field samples from domestic poultry populations in Vietnam: consequences for surveillance [J]. Vet Microbiol, 2012, 156(3-4): 277-84. 被引量:1
  • 4Tong S, Zhu X, Li Y, et al. New world bats harbor diverse influ- enzaAviruses[J]. PLoSPathog, 2013, 9(10): e1003657. 被引量:1
  • 5Zabolotskikh IB, Penzhoian GA, Musaeva TS, et al. Analysis of risk factors of fatal outcome in pregnant and puerperant patients with severe HIN1 influenza[J]. Anesteziol Reanimatoi, 2010, 11 (6): 30-2. 被引量:1
  • 6Ii'icheva TN, Romanovskaia AA, II'inykh FA, et al. Monitoring for influenza in population of Western Siberia in 2007-2009[J]. Zh Mikrobiol Epidemiol Immunobiol, 2010, 12(6): 26-30. 被引量:1
  • 7Sanchez Munoz-Torrero JF, Vicente L, Pacheco N, et al. Influ- enza vaccination and hospitalization in high risk patients[J]. Med Clin (Barc), 2009, 132(1): 12- 5. 被引量:1
  • 8Aguilar Diaz Fdel, C, Jimenez Corona ME, Ponce de-Leon-Ro- sales S. Influenza vaccine and healthcare workers[J]. Arch Meal Res, 2011, 42(8): 652-7. 被引量:1
  • 9Balkhy H. Avian influenza: the tip of the iceberg[J]. Ann Tho- rac Med, 2008, 3(4): 154-7. 被引量:1
  • 10Baranovich T, Webster RG, Govorkova EA. Fitness of neura- minidase inhibitor-resistant influenza A viruses[J]. Curt Opin Virol, 2011. 1(6): 574-81. 被引量:1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部